CD4:CD8比值与CD8计数对HIV感染者死亡预后价值有限
基于13个欧美队列、49865例ART初治且病毒抑制、CD4≥350细胞/μL的HIV感染者,分析CD4:CD8比值和CD8计数与死亡的关系。调整混杂后,两者与全因死亡的关联幅度很小,不足以作为独立预后标志物。
要点
- CD4:CD8比值低 tertile 全因死亡 aHR 1.11(95%CI 1.00-1.25),预后价值有限。
- CD8计数与全因死亡呈U形关联,高 tertile aHR 1.13(95%CI 1.01-1.26)。
- 两者对非AIDS死亡无显著预后证据,不宜单独用于风险分层。
核心结论
- 在病毒抑制且CD4≥350细胞/μL的ART患者中,CD4:CD8比值或CD8计数调整后与死亡的关联幅度过小,不足以作为独立预后标志物。
研究设计与样本
- 研究纳入13个欧洲和北美队列的HIV感染ART初治成人,1996-2010年启动ART,从CD4≥350细胞/μL且病毒抑制时开始随访。
- 采用分层Cox模型估计CD4:CD8比值三分位(0-0.40、0.41-0.64为参照、>0.64)和CD8计数三分位(0-760、761-1138为参照、>1138 cells/μL)的死亡风险比。
主要发现
- 随访276526人年,49865例患者中1834例死亡(249例AIDS相关、1076例非AIDS定义、509例未知/不可分类)。
- 调整其他因素后,CD4:CD8比值低三分位 vs 中三分位的全因死亡aHR为1.11(95%CI 1.00-1.25)。
- CD8计数与全因死亡呈U形关联,高三分位 vs 中三分位的aHR为1.13(95%CI 1.01-1.26)。
- AIDS相关死亡随CD4:CD8比值升高和CD8计数降低而下降;两者对非AIDS死亡预后证据不足。
临床怎么用
- 在病毒抑制且CD4≥350细胞/μL的ART患者中,不应单独使用CD4:CD8比值或CD8计数进行死亡风险分层。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count. METHODS: We used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-naive adults who started ART during 1996-2010, who were followed from the date they had CD4 count ≥350 cells/μL and were virologically suppressed (baseline). We used stratified Cox models to estimate unadjusted and adjusted (for sex, people who inject drugs, ART initiation year, and baseline age, CD4 count, AIDS, duration of ART) all-cause and cause-specific mortality hazard ratios for tertiles of CD4:CD8 ratio (0-0.40, 0.41-0.64 [reference], >0.64) and CD8 count (0-760, 761-1138 [reference], >1138 cells/μL) and examined the shape of associations using cubic splines. RESULTS: During 276526 person-years, 1834 of 49865 patients died (249 AIDS-related; 1076 non-AIDS-defining; 509 unknown/unclassifiable deaths). There was little evidence that CD4:CD8 ratio was prognostic for all-cause mortality after adjustment for other factors: the adjusted hazard ratio (aHR) for lower vs middle tertile was 1.11 (95% confidence interval [CI], 1.00-1.25). The association of CD8 count with all-cause mortality was U-shaped: aHR for higher vs middle tertile was 1.13 (95% CI, 1.01-1.26). AIDS-related mortality declined with increasing CD4:CD8 ratio and decreasing CD8 count. There was little evidence that CD4:CD8 ratio or CD8 count was prognostic for non-AIDS mortality. CONCLUSIONS: In this large cohort collaboration, the magnitude of adjusted associations of CD4:CD8 ratio or CD8 count with mortality was too small for them to be useful as independent prognostic markers in virally suppressed patients on ART.
引用
- Trickey A, May MT, Schommers P, et al. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). Clin Infect Dis. 2017. PMID: 28903507. doi:10.1093/cid/cix466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。